Literature DB >> 3005328

Isolation and characterization of the apolipoprotein E receptor from canine and human liver.

D Y Hui, W J Brecht, E A Hall, G Friedman, T L Innerarity, R W Mahley.   

Abstract

Previous results have demonstrated that liver membranes possess two distinct lipoprotein receptors: a low density lipoprotein (LDL) receptor that binds lipoproteins containing either apolipoprotein (apo-) B or apo-E, and an apo-E-specific receptor that binds apo-E-containing lipoproteins, but not the apo-B-containing LDL. This study reports the isolation and purification of apo-B,E(LDL) and apo-E receptors from canine and human liver membranes. The receptors were solubilized with the zwitterionic detergent 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate and were partially purified by DEAE-cellulose chromatography. The apo-B,E(LDL) receptor was isolated by affinity chromatography on LDL-Sepharose. The apo-E receptor, which did not bind to the LDL-Sepharose column, was then purified by using an HDLc (cholesterol-induced high density lipoprotein)-Sepharose affinity column and an immunoaffinity column. Characterization of the receptors revealed that the hepatic apo-B,E(LDL) receptor is similar to the extrahepatic LDL receptor with an apparent Mr = 130,000 on non-reducing sodium dodecyl sulfate-polyacrylamide gels. The apo-E receptor was found to be distinct from the apo-B,E(LDL) receptor, with an apparent Mr = 56,000. The purified apo-E receptor displayed Ca2+-dependent binding to apo-E-containing lipoproteins and did not bind to LDL or chemically modified apo-E HDLc. Antibodies raised against the apo-B,E(LDL) receptor cross-reacted with the apo-E receptor. However, an antibody prepared against the apo-E receptor did not react with the apo-B,E(LDL) receptor. The apo-E receptor also differed from the apo-B,E(LDL) receptor in amino acid composition, indicating that the apo-E receptor and the apo-B,E(LDL) receptor are two distinct proteins. Immunoblot characterization with anti-apo-E receptor immunoglobulin G indicated that the apo-E receptor is present in the hepatic membranes of man, dogs, rats, and mice and is localized to the rat liver parenchymal cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005328

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Characterization and isolation of a high-density-lipoprotein-binding protein from bovine corpus luteum plasma membrane.

Authors:  K Ferreri; K M Menon
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

2.  Immunocytochemical differential diagnosis of adrenocortical neoplasms using the monoclonal antibody D11.

Authors:  S Schröder; A Niendorf; E Achilles; M Dietel; B C Padberg; U Beisiegel; H Dralle; M Bressel; G Klöppel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Low density lipoprotein receptor-independent hepatic uptake of a synthetic, cholesterol-scavenging lipoprotein: implications for the treatment of receptor-deficient atherosclerosis.

Authors:  K J Williams; S Vallabhajosula; I U Rahman; T M Donnelly; T S Parker; M Weinrauch; S J Goldsmith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

4.  Lipoprotein binding to cultured human hepatoma cells.

Authors:  F Krempler; G M Kostner; W Friedl; B Paulweber; H Bauer; F Sandhofer
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

5.  Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism.

Authors:  M S Weintraub; R Zechner; A Brown; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

6.  Membrane binding sites for plasma lipoproteins on endosomes from rat liver.

Authors:  S Jaeckle; S E Brady; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

7.  Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.

Authors:  M S Weintraub; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

8.  Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein.

Authors:  U Beisiegel; W Weber; G Bengtsson-Olivecrona
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

9.  Uptake of retinyl ester in HL-60 cells via the low-density-lipoprotein-receptor pathway.

Authors:  K O Wathne; B Carlander; K R Norum; R Blomhoff
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

10.  A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve.

Authors:  J K Boyles; C D Zoellner; L J Anderson; L M Kosik; R E Pitas; K H Weisgraber; D Y Hui; R W Mahley; P J Gebicke-Haerter; M J Ignatius
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.